Abstract：ObjectiveTo study the influence of Thymopeptide Enteric Injection adjuvant chemotherapy on CD3+,CD4+, NK cell level in patients with ovarian cancer.MethodsFrom July 2013 to August 2016,98 patients with ovarian carcinoma treated in our hospital were studied,and they were divided into observation group and control group by using digital method,and there were 49 cases in each group.The patients in the observation group were given Thymopeptide Enteric Injection adjuvant chemotherapy,while the control group was given chemotherapy.CD3+,CD4+,NK cell level and so on between two groups were compared.ResultsAfter treatment,the excellent and good rate of the observation group was 95.92%,which was significantly higher than that of the control group(79.59%),and the difference was statistically significant(P＜0.05).After treatment,the level of CD3+,CD4+,and NK in the observation group were significantly higher than those in the control group,the difference was statistically significant(P＜0.01).Compared with before treatment,he white blood cell count,neutrophil count and the number of hemoglobin decreased in the two groups,and the improvement degree of WBC count and neutrophil count in the observation group was significantly better than that in the control group,the difference was statistically significant(P＜0.01).ConclusionThymopeptide Enteric Injection adjuvant chemotherapy treating patients with ovarian cancer can improve effectively CD3+,CD4+,and NK cell level,regulate the peripheral hemogram of the patients,improve the therapeutic effect.
Migueles SA，Connors M.Long-term nonprogressive disease among untreated HIV-infected individuals：clinical implications of understanding immune control of HIV[J].JAMA，2011，304（2）：194-201.
[10]
Kiesel P，Beck M，Johnson N.Monitoring CD4 in whole blood with an opto-fluidic detector based on spatially modulated fluorescence emission[J].Cytometry A，2011，79（4）：317-324.
[11]
Ji YI，Lee BY，Kang YJ，et al.Expression patterns of Thymosin β4and cancer stem cell marker CD133 in ovarian cancers[J].Pathol Oncol Res，2013，19（2）：237-245.
[12]
Kim YC，Kim BG，Lee JH，et al.Thymosin β10expression driven by the human TERT promoter induces ovarian cancerspecific apoptosis through ROS production[J].PLoS One，2012，7（5）：35399-35400.
[13]
Rho SB，Chun T，Lee SH，et al.The interaction between E-tropomodulin and thymosin beta-10 rescues tumor cells from thymosin beta-10 mediated apoptosis by restoring actin architecture[J].FEBS Lett，2004，557（1）：57-63.
[14]
Lee SH，Zhang W，Choi JJ，et al.Overexpression of the thymosin beta-10 gene in human ovarian cancer cells disrupts F-actin stress fiber and leads to apoptosis[J].Oncogene，2001，20（46）：6700-6706.
[15]
Kondakova IV，Iunusova NV，Spirina LV，et al.Association of intracellular proteinase activities with the content of locomotor proteins in tissues of primary tumors and metastasis in ovarian cancer[J].Bioorg Khim，2014，40（6）：735-742.
京公网安备 11010502046607号